Summary.-Monoclonal antibody against an osteogenic-sarcoma cell line (791T) was prepared by production and cloning of a somatic-cell hybrid between the mouse myeloma P3-NS1 and spleen cells from 791T-immunized mice. Three clones of a hybridoma producing antibody against 791T, as detected by 1251-labelled Protein A binding, were tested against a range of normal and tumour cell targets to determine the pattern of expression of the antigen detected. The 3 clones had identical activity. They reacted strongly against 791T cells and another osteogenic sarcoma, 788T, and more weakly against a further 2 from a total panel of 10 osteogenic-sarcoma lines. The antibody was negative for fibroblasts from the donor of 791T, and for other fibroblasts, human red blood cells, human peripheral mononuclear cells and sheep red blood cells. When tested against a panel of unrelated tumours, they reacted against individual cell lines derived from carcinomas of colon, lung, bladder and cervix. These cross-reactions were not observed with other colon or lung carcinomas, and it is suggested that the antibody was reacting with a tumour-associated antigen expressed randomly on different tumour types, rather than specifically on osteogenic sarcomas.
THE DETECTION of human tumourassociated cell-surface antigens has mainly been approached by in vitro methods, though a number of studies have claimed to demonstrate these antigens in vivo by the elicitation of cutaneous delayed type hypersensitivity reactions with tumour extracts (Hollinshead et al., 1974) . In vitro methods involving cellular immunity have often proved unreliable indicators of antigenicity (reviewed by Baldwin & Embleton, 1977) , partly owing to the presence of naturally reactive cells in normal populations. This has led to the exploitation of serological methods using patients' sera or absorbed xenogeneic sera, but again neither of these reagents is completely satisfactory. The production of monoclonal antibodies by somatic-cell hybrids promises to revolutionize the serology of human tumours by providing reagents of superior precision and specificity. This approach has been claimed to yield antibodies specific for cell-surface antigens of malignant melanoma (Yeh et al., 1979; Koprowski et al., 1978; Carrel et al., 1980) ; colon carcinoma and neuroblastoma (Kennet & Gilbert, 1979) . We now report the production of monoclonal antibodies to an osteogenic-sarcoma cell line and characterization of its reactivity towards a variety of other tumour types. P3NS1 cells, using 50% polyethylene glycol as previously described (Gunn et al., 1980) following the basic method of Galfre et al., (1977 (Gunn et al., 1980) . 125I Protein A binding test.-The assay was based on an 1251 anti-globulin binding test described previously (Gunn et al., 1980; Al-Sheikly et al., 1980 Absorption.-Hybridoma supernatant was diluted 1:10 and absorbed in some tests with cultured tumour cells at a concentration of 108 cells per ml of supernatant for 2 h at ambient temperature. The cells were removed by centrifugation and the absorbed supernatant tested for reactivity against selected targets (see text).
RESULTS
One fusion produced 48 growing hybrid cultures from 48 explants. All were screened for reactivity against 791T target cells and 5 were found initially to react significantly above control levels. Upon repeated testing only two (designated 791T/36 and 791T/48) were consistently positive, and these were further tested for reactivity against several other target cell lines ( Figure) . Both were positive for 791T and a second osteogenic sarcoma cell line, 788T, and the 791T/36 supernatant was also positive for a third osteogenic sarcoma, 805T. Reactivity of 791T/36 against a fourth sarcoma, 888T, was raised but not significantly different from background. All other tests were negative, and this includes 3 fibroblastic lines derived from the donor of the 791T cell line (860, 870 and 791SK, respectively). At this point the 791 T/36 hybridoma was cloned in soft agar.
Twelve clones were isolated and their supernatants tested against 791T cells, 791SK skin fibroblasts and two other cell lines (618 Lu normal lung cells and RAJ]. lymphoma cells). Nine clones were highly reactive with 791T cells and 3 more weakly so, but all were negative with the other target cells (Table I) this Table did so (see Table II ).
t Ct/min with P3NS1 spent medium. § Supernatant 791T/36 Clone 3 was diluted 1:10 and absorbed with 108 cells/ml at room temperature for 2 h. These conditions were based upon those used successfully with a monoclonal antibody to a rat breast carcinoma, which has a titre against relevant target cells of 1/1000 (Gunn et al., 1980) ; this was also the titre empirically determined for 791T/ 36 Clone 3. Table III shows (Table II) reductions of bound ct/min of between 70% and 90% were obtained after absorption. When the antibody was absorbed with non-crossreactive cells (Mel 2a, Mel 57, however, the reduction of activity against 791T cells was only 11-24%. These results support the specificity of the antibody demonstrable in direct tests.
DISCUSSION
Monoclonal antibodies were obtained from the cloned hybridoma 791T/36, which reacted preferentially with tumour cells. The antibody was strongly reactive with the immunizing osteogenic-sarcoma cell line, 791T, but was negative with fibroblasts obtained from the same patient (791SK, 860 and 870). It was also strongly reactive with a second osteogenic sarcoma, 788T, and more weakly reactive with another, 805T, but was negative with skin fibroblasts from the same patients (788SK and 805SK, respectively). This clearly demonstrates that the antibody was not reacting against human species-associated or histocompatibility antigens on the sarcoma cells. The antibody also failed to react with 25 other cultured human target cell lines, so was not directed against FCS components which are sometimes incorporated into the membrane of cells grown in medium containing this as a supplement (Embleton & Jype, 1978; Irie et al., 1974) . Red blood cells from volunteer donors, including all the major blood groups, did not react with the antibody, so it can not have been directed against blood-group antigens, which are sometimes expressed on tumour cells. Other ahtigens which can be discounted are DR antigens and Forssman antigen, since no reaction was obtained with peripheral mononuclear cells (containing both lymphocytes and monocytes) from 9 different donors, or with sheep red blood cells, respectively. It thus seems certain that the antibody was directed against a tumour-associated antigen.
However, the antigen detected was not shared by all the osteogenic sarcomas, since only 4/10 were positive, and was not exclusive to osteogenic sarcomas. Positive (and reproducible) cross-reactions were obtained with one cell line each derived from carcinomas of colon, lung, prostate and cervix. This does not represent a tissue-related cross-reactivity, because 2 other colon carcinomas and 2 lung carcinoma cell lines were negative. Rather,the picture is one of a randomly expressed tumour-associated antigen not associated with any particular histological type of tumour. This is at variance with the dogmatic view that human tumours express antigens common to tumours of a given tissue (discussed by Baldwin & Embleton, 1977) , which view appears to be supported by some of the early studies on monoclonal antibodies to human tumours, in which tissue-related specificity was reported (Koprowski et at., 1978; Yeh et al., 1979; Koprowski et al., 1979; Carrel et al., 1980) . However, preliminary results with clones derived from the second anti-791T hybridoma, 791T/48, confirm the present findings of random antigen expression (Embleton et al., to be published), and further support is provided by cross-reactions we have observed with anti-melanoma monoclonal antibodies (unpublished). Monoclonal antibodies potentially offer the best means of analysing the antigenic profiles of human solid tumours, and we suggest that the emergent picture may well be one of a spectrum of antigens, one or several of which may be expressed by any given tumour irrespective of histological type, perhaps in addition to differentiation antigens which might be tissue-related. If 
